Author Correction: A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax

• Nawapol Kunkeaw,
• Wang Nguitragool,
• Eizo Takashima,
• Niwat Kangwanrangsan,
• Hiromi Muramatsu,
• Mayumi Tachibana,
• Tomoko Ishino,
• Paulo J. C. Lin,
• Ying K. Tam,
• Sathit Pichyangkul,
• Takafumi Tsuboi,
• Norbert Pardi,
• Jetsumon Sattabongkot

Affiliations

Nawapol Kunkeaw

Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University

Wang Nguitragool

Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University

Eizo Takashima

Division of Malaria Research, Proteo-Science Center, Ehime University

Niwat Kangwanrangsan

Department of Pathobiology, Faculty of Science, Mahidol University

Hiromi Muramatsu

Department of Microbiology, Perelman School of Medicine, University of Pennsylvania

Mayumi Tachibana

Division of Molecular Parasitology, Proteo-Science Center, Ehime University

Tomoko Ishino

Department of Parasitology and Tropical Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University

Paulo J. C. Lin

Acuitas Therapeutics

Ying K. Tam

Acuitas Therapeutics

Sathit Pichyangkul

Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University

Takafumi Tsuboi

Division of Malaria Research, Proteo-Science Center, Ehime University

Norbert Pardi

Department of Microbiology, Perelman School of Medicine, University of Pennsylvania

Jetsumon Sattabongkot

Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University